MAP2K1 and ovarian carcinoma: Our risk model, composed of six proteins (GSK3α/β, HSP70, MEK1, MTOR, BAD, and NDRG1), can predict survival of ovarian cancer patients effectively, thereby helping prognosis monitoring and decision making.